Related references
Note: Only part of the references are listed.Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection
Noboru Shinkai et al.
HEPATOLOGY RESEARCH (2006)
Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B
Anna Rodella et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C
Mariko Kobayashi et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: An update
Emmet B. Keeffe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C
Etsuro Orito et al.
HEPATOLOGY RESEARCH (2006)
Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants
F Suzuki et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B
A Tsubota et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Adefovir dipivoxil for treatment of breakthrough hepatitis caused by lamivudine-resistant mutants of hepatitis B virus
T Hosaka et al.
INTERVIROLOGY (2004)
Core promoter/pre-core mutations are associated with lamivudine-induced HBeAg loss in chronic hepatitis B with genotype C
Y Asahina et al.
JOURNAL OF HEPATOLOGY (2003)
Diagnosis and management of pre-core mutant chronic hepatitis B
GV Papatheodoridis et al.
JOURNAL OF VIRAL HEPATITIS (2001)
Hepatitis B infection in patients with acute liver failure in the United States
EK Teo et al.
HEPATOLOGY (2001)
Clinical relevance of hepatitis B viral mutations
CM Hunt et al.
HEPATOLOGY (2000)
Share Paper
